天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> Journal of Drugs in Dermatology >>article
Journal of Drugs in Dermatology

Journal of Drugs in Dermatology

IF: 1.5
Download PDF

Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study.

Published:1 March 2023 DOI: 10.36849/JDD.7165 PMID: 36877880
Charles Kircik, Leon Kircik

Abstract

Background: The well-established sequential use of topical calcipotriene and topical betamethasone dipropionate in combination has been shown to provide greater benefit than either monotherapy. A newer topical fixed combination formulation of calcipotriene 0.005% and betamethasone dipropionate 0.064% in a cream base (Cal/BD cream) is effective with high patient ratings for convenience and tolerability. The current study compares patient satisfaction between Cal/BD foam and Cal/BD cream formulations. Study Design and Patient Demographics: This is a single-use, split body, open label study involving 20 subjects. Ten subjects additionally had scalp psoriasis. Study treatments were applied by the investigator in a randomized manner and patients completed questionnaires to assess treatment preferences.

Findings: Both Cal/BD formulations provided rapid and significant improvement in symptoms of pruritus, stinging, burning, and pain; with no statistically significant difference in response between the 2 treatments. Overall, Cal/BD cream outperformed Cal/BD foam on several key measures for vehicle features and patient satisfaction. For non-scalp application, 55% of subjects preferred Cal/BD cream over Cal/BD foam. For the scalp, 60% of subjects preferred Cal/BD cream over Cal/BD foam. No adverse events were reported during the study.

Conclusion: Results of this current study indicate high levels of patient satisfaction with Cal/BD cream and a preference for the cream base over foam for the treatment of body and scalp psoriasis. ? J Drugs Dermatol. 2023;22(3): doi:10.36849/JDD.7165.

Substances (4)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Betamethasone 17,21-dipropionate 5593-20-4 C28H37FO7 434 suppliers $42.00-$704.00
Calcipotriene 112828-00-9 C27H40O3 171 suppliers $56.00-$1960.00
5 KG YEAST EXTRACT SERVABACTERPOWDER 15 suppliers Inquiry
Container, Foam, Large 5 suppliers Inquiry

Similar articles

IF:2.8

Evaluation of Bioequivalence and Pharmacokinetic Profiles for Topical Desonide Cream Using Chinese Skins.

Skin Pharmacology and Physiology Yuanyuan Sun,?Nan Yang,etc Published: 19 August 2024
IF:12.8

The importance of dual 5α-reductase inhibition in?the?treatment of male pattern hair loss: Results?of?a?randomized placebo-controlled study?of?dutasteride versus finasteride

Journal of the American Academy of Dermatology Elise A. Olsen MD , Maria Hordinsky MD ,etc Published: 1 December 2006